Alexandre Akoulitchev
Gründer bei OXFORD BIODYNAMICS PLC
Vermögen: 706 068 $ am 30.04.2024
Aktive Positionen von Alexandre Akoulitchev
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OXFORD BIODYNAMICS PLC | Direktor/Vorstandsmitglied | 08.06.2007 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 08.06.2007 | - | |
| Gründer | 23.04.2007 | - | |
| Sibelius Ltd. | Direktor/Vorstandsmitglied | - | - |
| Wittgenstean Associates Ltd. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Alexandre Akoulitchev
Ehemalige bekannte Positionen von Alexandre Akoulitchev
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Chronos Therapeutics Ltd.
 Chronos Therapeutics Ltd. BiotechnologyHealth Technology Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom. | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Alexandre Akoulitchev
| University College London | Doctorate Degree |
| University of Oxford | Graduate Degree |
Statistik
International
| Vereinigtes Königreich | 7 |
Operativ
| Director/Board Member | 4 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OXFORD BIODYNAMICS PLC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Sibelius Ltd. | |
| Wittgenstean Associates Ltd. | |
Chronos Therapeutics Ltd.
Chronos Therapeutics Ltd. BiotechnologyHealth Technology Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Alexandre Akoulitchev
- Erfahrung
